Key result
Apixaban reversal for adrenal hemorrhage in active DVT and HIT requires individualized anticoagulation strategies.
Why the study?
Guideline-directed anticoagulation reversal strategies are limited at the intersection of bilateral adrenal hemorrhage, active thrombosis, and heparin-induced thrombocytopenia.
This case underscores the importance of individualized, interdisciplinary decision-making in managing complex anticoagulation scenarios involving active thrombosis, HIT, and bleeding requiring reversal.
Answers are grounded in this paper and cite their sources.
Individualized interdisciplinary care is essential in HIT with thrombosis and hemorrhage; leaves open optimal reversal protocols pending further evidence.
This case illustrates the intersection of BAH, active thrombosis, and HIT, where guideline-directed reversal strategies are limited. It underscores the challenges of selecting and timing anticoagulation reversal in patients with recent thrombotic events and contraindications to standard agents, highlighting the importance of individualized, interdisciplinary decision-making in managing complex anticoagulation scenarios.
No takes yet. Share an insight, caveat, or question.
Lichardi et al. (2026) studied this question. Management of adrenal hemorrhage with apixaban reversal in active DVT and HIT requires individualized anticoagulation strategies due to limited guideline options.
Synapse has enriched 10 related papers. Consider them for comparative context: